Author

S. Battaglia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

K. Odunsi· 3 shared R. MUTHUSWAMY· 2 shared A. Amobi-McCloud· 1 shared A. Barbova· 1 shared A. Cabibbe· 1 shared A. Dean· 1 shared A. Lugade· 1 shared A. Miliotto· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

K. Odunsi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Indoleamine 2,3-dioxygenase upregulates PD-1 expression on ovarian tumor infiltrating CD8+ T cells via kynurenine activation of the aryl hydrocarbon receptor

A. Amobi-McCloud, R. MUTHUSWAMY, S. Battaglia, H. Yu, T. Liu, J. Wang, V. Putluri, P. K. Singh, F. Qian, R.-Y. Huang, N. Putluri, T. Takemasa, A. Lugade, S. Liu, K. Odunsi

This study shows that IDO1 promotes PD-1 expression on CD8+ T cells in ovarian tumors through kynurenine-mediated AHR activation, suggesting therapeutic targeting of these pathways.

bioRxiv · Feb 18, 2021 · PreprintImmunology

CXCR6 by increasing retention of memory CD8 T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer

R. Muthuswamy, A. R. McGray, S. Battaglia, W. He, A. Miliotto, C. A. Eppolito, B. D. Litchy, P. Shrikant, K. Odunsi, K. Odunsi

This study identifies CXCR6 as a marker for resident memory CD8 T cells in ovarian cancer, showing its role in enhancing tumor immunosurveillance through increased retention of these cells in the tumor microenvironment.

bioRxiv · Dec 2, 2020Immunology

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

T. Yamauchi, T. Hoki, T. Oba, V. Jain, H. Chen, K. Attwood, S. Battaglia, S. George, G. Chatta, I. Puzanov, C. Morrison, K. Odunsi, B. H. Segal, G. K. Dy, M. S. Ernstoff, F. Ito

The paper identifies CX3CR1 expression on circulating CD8+ T cells as a biomarker predicting response to immune checkpoint inhibitor therapy in NSCLC patients.

bioRxiv · Jun 13, 2020Immunology

Characterization of genomic variants associated with resistance to bedaquiline and delamanid in naïve Mycobacterium tuberculosis clinical strains

S. Battaglia, A. Spitaleri, A. Cabibbe, C. Meehan, C. Utpatel, N. Ismail, S. Tahseen, A. Skrahina, N. Alikhanova, K. S. Mostofa, A. Barbova, S. Niemann, R. Groenheit, A. Dean, M. Zignol, , D. Cirillo

This study identifies genetic mutations associated with resistance to bedaquiline and delamanid in Mycobacterium tuberculosis strains using whole genome sequencing and in silico analysis.

bioRxiv · May 27, 2020Microbiology